Frontlight ResearchEarly access
Trial site
Centrum Medyczne Pratia Poznan
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- and 4 more
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Amgen1 trial
- Eli Lilly and Company1 trial
- G1 Therapeutics, Inc.1 trial
- Genmab1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
Closed trials
Terminated
Completed
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026